The recombinant UU127 protein is expressed in E. coli using plasmid systems such as pTrcHis TOPO, enabling His-tagged purification . Key specifications include:
| Parameter | Details |
|---|---|
| Source Organism | Ureaplasma parvum serovar 3 |
| Expression Host | E. coli |
| Tag | N-terminal His-tag |
| Protein Length | Full-length (1–101 amino acids) |
| Purity | >90% (SDS-PAGE-verified) |
| Storage Buffer | Tris/PBS-based buffer with 6% trehalose (pH 8.0) |
The protein’s amino acid sequence is:
MKIIGSAFLGIVFCILLAFAIIFGIEIDYYHQGDYLKYLNFLDKLHQYNKIDNSFEYSNH YESALIGVIVLTIICFLIFITPIIIIVITKIKEKKVINKKI .
UU127 is utilized in Western blotting and ELISA to detect Ureaplasma-specific antibodies. Key findings include:
Cross-reactivity: Recombinant UU127 (rUU127) exhibits cross-reactivity with monoclonal antibodies (MAbs) targeting other U. parvum serotypes (e.g., serovars 1, 6, and 14) in ELISA, suggesting conserved epitopes .
Serotype-specific reactivity: Strong binding to homologous MAbs in Western blotting, confirming its utility in serotyping .
While UU127 itself is not directly targeted by primers, related U. parvum genes (e.g., UP063) are used in PCR-based detection systems to distinguish U. parvum from U. urealyticum. For example:
| Target Gene | Primer/Probe | Sequence | Amplicon Size |
|---|---|---|---|
| UP063 | UP063#1F | TGCGGTGTTTGTGAACT | 152 bp |
| UP063#1R | TGATCAAACTGATATCGCAATTATAGA |
This highlights the broader genomic context for Ureaplasma detection .
Despite its genomic presence, UU127’s biological function remains undefined. It is classified as a hypothetical protein, underscoring gaps in understanding Ureaplasma pathogenicity mechanisms.
Host-cell interaction (e.g., adhesion, invasion).
Immune evasion (e.g., antigenic variation).
rUU127 demonstrates notable cross-reactivity with MAbs from non-homologous serotypes, as observed in:
| Serotype | MAb Target | Reactivity |
|---|---|---|
| 3 | Homologous MAb | Strong (expected) |
| 14 | MAb | Moderate |
| 1 | MAb | Low |
This suggests shared epitopes or structural similarities across U. parvum serotypes .
Studies on UU127 should prioritize:
Functional characterization (e.g., knockout models).
Antigenic diversity (e.g., epitope mapping).
Diagnostic optimization (e.g., multiplex assays).
KEGG: uur:UU127
STRING: 273119.UU127
UU127 is an uncharacterized protein from Ureaplasma parvum serovar 3 that consists of 101 amino acids. The complete amino acid sequence is: MKIIGSAFLGIVFCILLAFAIIFGIEIDYYHQGDYLKYLNFLDKLHQYNKIDNSFEYSNHYESALIGVIVLTIICFLIFITPIIIIVITKIKEKKVINKKI . Based on its sequence analysis, UU127 appears to be a membrane-associated protein with hydrophobic regions, suggesting it may be involved in membrane integrity or cellular interactions. The protein has a UniProt ID of Q9PR17 and is commonly expressed with tags (such as His-tag) for research purposes .
Recombinant UU127 is typically produced using E. coli expression systems. The full-length protein (amino acids 1-101) is expressed with an N-terminal His-tag to facilitate purification . The expression construct contains the complete UU127 gene sequence, and the resulting protein is purified using affinity chromatography methods. After purification, the protein is commonly supplied as a lyophilized powder for research applications . It's important to note that the expression in E. coli may result in structural differences compared to the native protein due to the absence of post-translational modifications that might occur in Ureaplasma.
For optimal stability and activity of recombinant UU127 protein, the following storage and reconstitution protocols are recommended:
| Parameter | Recommendation |
|---|---|
| Storage temperature | -20°C/-80°C upon receipt |
| Aliquoting | Necessary for multiple use |
| Reconstitution | In deionized sterile water to 0.1-1.0 mg/mL |
| Buffer | Tris/PBS-based buffer, pH 8.0 |
| Cryoprotectant | 6% Trehalose in buffer; add 5-50% glycerol for long-term storage |
| Handling notes | Briefly centrifuge vial before opening; avoid repeated freeze-thaw cycles |
For long-term storage stability, adding glycerol to a final concentration of 50% is recommended after reconstitution .
The purity of commercially available recombinant UU127 protein typically exceeds 90% as determined by SDS-PAGE . Researchers should independently verify protein integrity through:
SDS-PAGE analysis to confirm molecular weight and purity
Western blot analysis using anti-His tag antibodies to confirm identity
Mass spectrometry for precise molecular weight determination and sequence verification
Circular dichroism spectroscopy to assess secondary structure integrity
Dynamic light scattering to evaluate protein homogeneity and aggregation state
These analytical methods collectively provide comprehensive validation of protein quality before experimental use.
To elucidate the function of UU127, researchers can employ several complementary approaches:
Structural analysis: X-ray crystallography, NMR spectroscopy, or cryo-EM to determine three-dimensional structure
Protein-protein interaction studies: Pull-down assays, yeast two-hybrid screening, or proximity labeling to identify binding partners
Subcellular localization: Immunofluorescence microscopy using antibodies against UU127 or tagged versions of the protein
Gene knockout/knockdown studies: CRISPR-Cas9 or RNAi approaches in appropriate model systems
Comparative genomics: Bioinformatic analysis across Ureaplasma species and serovars to identify conserved domains and putative functions
Functional assays: Based on predicted functions from sequence analysis (e.g., membrane association assays)
Given the membrane-associated nature of UU127 suggested by its sequence, particular attention should be paid to potential roles in bacterial adhesion, host-cell interaction, or membrane integrity.
For specific and sensitive detection of UU127 protein:
Immunological methods: Develop specific antibodies against UU127 for Western blot, ELISA, or immunofluorescence microscopy
Mass spectrometry: For precise identification and quantification in complex samples
Real-time PCR: For gene expression analysis using primers specific to the UU127 gene
Recombinant expression with tags: His-tagged or fluorescently tagged versions for tracking in experimental systems
For detection of the parental organism (Ureaplasma parvum serovar 3), multiplex real-time PCR methods have been developed with high sensitivity. The detection limit for U. parvum using these methods is approximately 2.8 × 10^-2 CFU/μl PCR mixture, which allows for highly sensitive detection in experimental and clinical samples .
When investigating UU127 interactions with host cells, consider these experimental approaches:
Cell binding assays: Fluorescently labeled UU127 protein can be used to quantify binding to different host cell types
Competitive inhibition studies: Using antibodies against UU127 or synthetic peptides mimicking portions of UU127 to block interactions
Cell culture infection models: Compare wild-type Ureaplasma with UU127 knockout/knockdown strains to assess changes in host cell adhesion, invasion, or inflammatory responses
Pull-down assays: Identify potential host cell receptors using His-tagged UU127 as bait
Proximity labeling approaches: BioID or APEX2 fusion proteins to identify proximal interacting proteins in living cells
Control experiments should include other Ureaplasma proteins and heat-inactivated UU127 to confirm specificity of any observed interactions.
As UU127's sequence suggests membrane association, determining its precise topology is crucial:
Protease protection assays: Using proteases to digest exposed protein regions in intact bacterial cells
Substituted cysteine accessibility method (SCAM): Introducing cysteine residues at various positions and testing their accessibility
Immunogold electron microscopy: Using antibodies against UU127 with gold-conjugated secondary antibodies for precise localization
Fluorescence microscopy: Using GFP-tagged UU127 in live cell imaging studies
Membrane fractionation: Separation of inner and outer membranes followed by Western blot analysis
Computational prediction: Using multiple topology prediction algorithms (TMHMM, HMMTOP, etc.) to generate consensus models
Comparing experimental results with bioinformatic predictions can provide robust evidence for membrane topology and subcellular localization.
To explore UU127's potential roles in pathogenesis:
Gene knockout studies: Create UU127 deletion mutants and assess virulence in cell culture or animal models
Heterologous expression: Express UU127 in non-pathogenic bacterial species to assess gain of function
Host response analysis: Measure cytokine production, inflammatory markers, and cell signaling pathways in response to purified UU127
Comparative genomics: Analyze UU127 sequence conservation across clinical isolates with varying virulence
Adhesion and invasion assays: Compare wild-type and UU127-deficient strains in their ability to adhere to and invade host cells
Transcriptomics and proteomics: Analyze host cell responses to UU127 exposure using RNA-seq and mass spectrometry
These approaches may reveal whether UU127 functions as an adhesin, invasin, immune modulator, or has other pathogenicity-related functions.
Distinguishing UU127 from homologs in other Ureaplasma serovars presents several challenges:
Sequence similarity: Homologous proteins in different serovars may share high sequence identity, complicating specific detection
Cross-reactivity: Antibodies may recognize epitopes common to multiple homologs
Limited annotation: Many Ureaplasma proteins remain uncharacterized, making comparative analyses difficult
Variable expression: Homologous proteins may be differentially expressed under various conditions
For serovar-specific detection, real-time PCR assays targeting unique genomic regions have been developed . These assays can distinguish U. parvum (including serovar 3) from U. urealyticum with high sensitivity and specificity. For UU127 specifically, researchers should design primers and probes that target unique regions of the gene that differ between serovars. The analytical sensitivity of these PCR methods has been demonstrated to reach 2.8 × 10^-2 CFU/μl for U. parvum detection .
Researchers may encounter several challenges when working with recombinant UU127:
| Challenge | Solution |
|---|---|
| Protein aggregation | Add mild detergents (0.01-0.1% Triton X-100) during reconstitution; optimize buffer conditions |
| Low solubility | Use solubility enhancers like arginine or proline; try different pH conditions |
| Degradation | Add protease inhibitors; store in aliquots; avoid repeated freeze-thaw cycles |
| Poor antibody recognition | Try different epitopes; use tag-specific antibodies; validate with Western blot |
| Loss of activity during storage | Store with glycerol at -80°C; prepare fresh working solutions |
| Expression toxicity in E. coli | Use tightly controlled inducible expression systems; optimize growth conditions |
Most commercially available recombinant UU127 is supplied with specific reconstitution buffers optimized to maintain stability . Following manufacturer recommendations for reconstitution and storage can minimize many of these issues.
When interpreting UU127 functional studies:
Consider bacterial context: In vitro results with purified protein may not reflect its function within intact bacteria
Evaluate concentration effects: Use physiologically relevant concentrations; dose-response studies are essential
Validate with multiple approaches: Confirm findings using complementary methodologies
Compare with clinical isolates: Test whether laboratory findings translate to clinical strains
Control for contaminants: Ensure effects are not due to endotoxin or other bacterial components
Account for host factors: Consider how host cell type, species, and conditions affect results
Research findings should be analyzed in the context of the polymicrobial nature of many Ureaplasma infections, considering that UU127 may function differently in complex microbial communities than in isolation.
For robust statistical analysis of UU127 interaction studies:
Appropriate replication: Minimum three biological replicates with multiple technical replicates
Control selection: Include both positive and negative controls (e.g., heat-inactivated protein, unrelated proteins)
Normalization methods: Account for batch effects and experimental variations
Statistical tests:
For comparison between two groups: Student's t-test or Mann-Whitney U test
For multiple comparisons: ANOVA with appropriate post-hoc tests (Tukey, Bonferroni)
For dose-response data: Regression analysis or EC50 determination
Effect size calculation: Report not only p-values but also effect sizes
Power analysis: Ensure adequate sample size to detect biologically relevant differences
Researchers should be cautious about data interpretation, especially when observed effects are subtle, and should consider both statistical significance and biological relevance.
Several cutting-edge technologies show promise for elucidating UU127 function:
Cryo-electron microscopy: For high-resolution structural analysis, especially in membrane contexts
AlphaFold and other AI-based structure prediction: To generate structural models when experimental structures are unavailable
CRISPR interference (CRISPRi): For precise modulation of UU127 expression in Ureaplasma
Single-cell analysis: To understand heterogeneity in UU127 expression across bacterial populations
Organoid models: For studying host-pathogen interactions in more physiologically relevant systems
Microfluidics: For real-time analysis of UU127-host interactions under controlled conditions
Native mass spectrometry: For analyzing membrane protein complexes involving UU127
The integration of computational and experimental approaches will likely provide the most comprehensive understanding of this uncharacterized protein's function.
Research on UU127 may contribute to understanding Ureaplasma pathogenesis in several ways:
Identification of new virulence factors: If UU127 proves important for colonization or virulence
Novel therapeutic targets: Potential for developing inhibitors if UU127 serves an essential function
Diagnostic markers: Possibility of using UU127 or antibodies against it for improved detection
Pathogenesis mechanisms: Insights into how Ureaplasma establishes infection and causes disease
Host-pathogen interactions: Understanding of how Ureaplasma proteins interact with host cells
Evolutionary adaptations: Insights into how Ureaplasma has evolved to colonize the human urogenital tract
As an uncharacterized protein, UU127 represents an opportunity to discover novel aspects of Ureaplasma biology that may have significant implications for understanding and addressing infections.